Search

everythinglearnresearchcommunity

for

Search:↓

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

TNF-alpha inhibitors can cause various immune-related skin issues.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Certain long non-coding RNAs in cashmere goats affect hair growth when treated with a specific growth factor.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Cytokeratins 15 and 19 may help track vitiligo treatment progress.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Estrogen and MLL enzymes work together to regulate genes important for hair growth and leukemia.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.